Cancer Straight Talk: Breakthrough Rectal Cancer Drug Trial: What It Means For You


A recent clinical trial for rectal cancer headed up by Memorial Sloan Kettering has grabbed the attention of medical oncologists and cancer scientists around the world. Like a miracle, in a subset of patients with the right genetic makeup, an IV infusion of an immunotherapy caused a complete remission. The doctors were shocked. The cancer disappeared in every single patient enrolled on trial. The results are so impressive they were published in The New England Journal of Medicine and featured at the nation’s largest gathering of clinical oncologists in June 2022.

In this episode, Dr. Diane Reidy-Lagunes speaks with the designers of this study, Drs. Andrea Cercek and Luis Diaz, on what this groundbreaking news means for cancer patients and the scientific community moving forward.

Learn more about MSK’s Center for Young Onset Colorectal and Gastrointestinal Cancer.


For more information and to ask a question, please visit

Last Updated

Friday, October 14, 2022